Market revenue in 2024 | USD 1,177.2 million |
Market revenue in 2030 | USD 1,944.0 million |
Growth rate | 8.6% (CAGR from 2025 to 2030) |
Largest segment | Cartridges |
Fastest growing segment | Vials |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Vials, Prefilled Syringes, Cartridges |
Key market players worldwide | Boehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.
Cartridges was the largest segment with a revenue share of 26.41% in 2024. Horizon Databook has segmented the UK fill-finish pharmaceutical contract manufacturing market based on vials, prefilled syringes, cartridges covering the revenue growth of each sub-segment from 2018 to 2030.
In the UK, fill-finish contract manufacturing is an important part of the pharmaceutical industry. The number of CMOs that specialize in fill-finish contract manufacturing is growing in the UK owing to the increasing demand in the market.
These companies generally have state-of-the-art facilities and equipment, as well as highly skilled personnel, to ensure that products are manufactured as per the highest quality standards. One of the key advantages of using a CMO for fill-finish contract manufacturing is that it allows pharmaceutical companies to outsource a critical part of the manufacturing process, which can be costly and time-consuming to perform in-house.
By partnering with a CMO, pharmaceutical companies can benefit from the CMO's expertise, experience, and specialized equipment, while also reducing its capital expenditure. Overall, the fill-finish contract manufacturing scenario in the UK is robust and competitive, with a number of high-quality CMOs offering a range of services to pharmaceutical companies.
Horizon Databook provides a detailed overview of country-level data and insights on the UK fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UK fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account